ASSET LIABILITY MANAGEMENT IN INDIAN BANKS AT UNION BANK OF INDIA
JDEBM · 31.03.2026 · 509
DOI: 10.65713/jdebmv2i172 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDEBM, online erschienen am 31.03.2026. Verfasst von Mr VR RAMAKRISHNA und 1 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
The ALM practices of Union Bank of India are the subject of this research, which looks at how the bank handles funding needs, interest rate risk, and liquidity in a changing financial environment. The research examines trends in the bank's asset-liability composition, liquidity coverage, and gap management strategies by utilizing secondary data from annual reports, Reserve Bank of India publications, and other financial statements from the last five years. The research shows that Union Bank of India uses a number of ALM tools, like maturity gap analysis, duration analysis, and interest rate sensitivity management, to make sure it has enough liquidity and to lower its financial risk. The results show that good ALM practices have helped the bank stay stable during times of economic uncertainty and changes in regulations. They have also made the bank more profitable and less reliant on borrowing from other banks. The research emphasizes the necessity of a resilient ALM framework for Indian public sector banks and offers suggestions for improving risk management, particularly in light of increasing interest rate volatility and changing banking regulations.
Zitieren
APA
RAMAKRISHNA, M. V., & SIVANI, P. (2026). ASSET LIABILITY MANAGEMENT IN INDIAN BANKS AT UNION BANK OF INDIA. JDEBM, 509. https://doi.org/10.65713/jdebmv2i172
Vancouver
RAMAKRISHNA MV, SIVANI P. ASSET LIABILITY MANAGEMENT IN INDIAN BANKS AT UNION BANK OF INDIA. JDEBM. 2026:509. doi:10.65713/jdebmv2i172
BibTeX
@article{RAMAKRISHNA2026,
author = {RAMAKRISHNA, Mr VR and SIVANI, PATHAKAMOORI},
title = {ASSET LIABILITY MANAGEMENT IN INDIAN BANKS AT UNION BANK OF INDIA},
journal = {JDEBM},
year = {2026},
pages = {509},
doi = {10.65713/jdebmv2i172}
}
EUVIMED